Hunter Immunology Overview
- Founded
- 2003
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
Hunter Immunology General Information
Description
Developer of medicinal drugs intended to treat patient suffering from chronic obstructive pulmonary disease (COPD).
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Probiomics
Primary Office
- Avalon Parade 61
- Sydney, New South Wales 2107
- Australia
Hunter Immunology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Hunter Immunology‘s full profile, request access.
Request a free trialHunter Immunology Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| David Radford | Chief Executive Officer |